LGMD R6 (2F, δ-sarcoglycan-related) is characterized by 26 known pathogenic mutations of the SGCD gene, with the majority being nonsense mutations and frameshift mutations. This evidence concerns the gene SGCD and limb-girdle muscular dystrophy.